Search results
Google's new CFO Anat Ashkenazi raked in a nearly $10 million signing bonus
Business Insider via Yahoo News· 1 day agoAlphabet, Inc. appointed Anat Ashkenazi as its new Chief Financial Officer to oversee Alphabet and...
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
Investor's Business Daily· 2 months agoThe quest to treat Alzheimer's disease is heating up as drugmakers Eli Lilly, Biogen and Roche blaze...
The CEO of pharma giant Eli Lilly shares 3 ways AI could transform his industry
Business Insider via Yahoo Finance· 12 months agoDavid Ricks, the CEO of Eli Lilly.Eli Lilly Biotech and pharma companies are evaluating how AI could...
Stock-Split Watch: Are These 2 Top Growth Stocks Next?
Motley Fool via Yahoo Finance· 2 months agoAre stock splits back in style? About two years ago, a number of high-profile corporations made such...
Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid...
Motley Fool via Yahoo Finance· 5 months agoWhen it comes to the pharmaceutical industry, weight-loss medications are all the rage right now....
Zacks Investment Ideas feature highlights: DraftKings, Eli Lilly and Emerson Electric
Zacks via Yahoo Finance· 10 months agoFor Immediate Release Chicago, IL – August 9, 2023 – Today, Zacks Investment Ideas feature...
Stocks trending in afternoon trading: Beyond Meat, Eli Lilly, and Palantir
Yahoo Finance· 10 months agoCorporate results were driving big moves in a variety of stocks on Tuesday afternoon, while a...
3 No-Brainer Growth Stocks to Buy in December
Motley Fool· 6 months agoThree Motley Fool contributors believe they've identified such exceptions. Here's why they think Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and...
Forget Nvidia, These Unstoppable Stocks Are Better Buys
Motley Fool via Yahoo Finance· 1 month agoNvidia has been an amazing stock to own over the past few years, generating incredible returns for...
Better Buy Now: Novo Nordisk vs. Eli Lilly
Motley Fool· 7 months agoNovember isn't half-finished, and it's already shaping up to be an exciting month for pharmaceutical companies that market weight-management drugs. On...